Legal and Economic Perspectives Concerning US Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2009-01, Vol.27 (8), p.623-625
Hauptverfasser:	Kalb, Paul E., Greenberg, Paul E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Accountability Cancer therapies Chronic illnesses Drug Approval - legislation & jurisprudence Drug Industry - economics Drug Industry - legislation & jurisprudence Drug Labeling - economics Drug Labeling - legislation & jurisprudence Drugs Editorial Editorials FDA approval Federal Government Fraud Government investigations Health Administration Health Economics Health technology assessment Humans Investigations Laws, regulations and rules Legislation, Drug Marketing Marketing - economics Marketing - legislation & jurisprudence Medicaid Medicare Medicine Medicine & Public Health Oncology Patients Pharmaceutical industry Pharmacoeconomics and Health Outcomes Physicians Prescription drugs Public Health Quality of Life Research United States United States Food and Drug Administration - legislation & jurisprudence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!